Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2018 | Research article

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom

Authors: Pamela Vo, Juanzhi Fang, Aikaterini Bilitou, Annik K. Laflamme, Shaloo Gupta

Published in: The Journal of Headache and Pain | Issue 1/2018

Abstract

Background

Migraine is a distinct neurological disease that imposes a significant burden on patients, society, and the healthcare system. This study aimed to characterize the incremental burden of migraine in individuals who suffer from ≥4 monthly headache days (MHDs) by examining health-related quality of life (HRQoL), impairments to work productivity and daily activities, and healthcare resource utilization (HRU) in the EU5 (France, Germany, Italy, Spain, United Kingdom).

Methods

This retrospective cross-sectional study used data from the 2016 National Health and Wellness Survey (NHWS; N = 80,600). Short-Form 36-Item Health Survey, version 2 (SF-36v2) physical and mental component summary scores (PCS and MCS), Short-form-6D (SF-6D), and EuroQoL (EQ-5D), impairments to work productivity and daily activities (Work Productivity and Activity Impairment Questionnaire (WPAI), and HRU were compared between migraine respondents suffering from ≥4 MHDs (n = 218) and non-migraine controls (n = 218) by propensity score matching using sociodemographic characteristics. Chi-square, T-tests, and Mann-Whitney tests were performed to determine significant differences between the groups after propensity score matching.

Results

HRQoL was lower in migraine individuals suffering from ≥4 MHDs compared with non-migraine controls, with reduced SF-36v2 PCS (46.00 vs 50.51) and MCS (37.69 vs 44.82), SF-6D health state utility score (0.62 vs 0.71), and EQ-5D score (0.68 vs 0.81) (for all, p < 0.001). Respondents with migraine suffering from ≥4 MHDs also reported higher levels of absenteeism from work (14.43% vs 9.46%; p = 0.001), presenteeism (35.52% vs 20.97%), overall work impairment (38.70% vs 23.27%), and activity impairment (44.17% vs 27.75%) than non-migraine controls (for all, p < 0.001). Additionally, HRU was significantly higher for individuals with ≥4 MHDs compared to their matched controls. Consistently, migraine subgroups (4–7 MHDs, 8–14 MHDs and CM) had lower HRQoL, greater overall work and activity impairment, and higher HRU compared to non-migraine controls.

Conclusions

Migraine of ≥4 MHDs was associated with poorer HRQoL, greater work productivity loss, and higher HRU compared with non-migraine controls. The findings of the study suggest that an unmet need exists among individuals suffering from ≥4 MHDs in the EU5 suggesting the need for effective prophylactic treatments to lessen the humanistic and economic burden of migraine.

(2013) The International Classification of Headache Disorders, 3rd edition Copyright. ßInternational Headache Soc. doi: https://doi.org/10.1177/0333102417738202

Donnet A, Daniel C, Milandre L et al (2012) Migraine with aura in patients over 50 years of age: the Marseille’s registry. J Neurol 259:1868–1873. https://doi.org/10.1007/s00415-012-6423-8 CrossRefPubMed

Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 Suppl 1:9–160.

Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349. https://doi.org/10.1212/01.wnl.0000252808.97649.21 CrossRefPubMed

Woldeamanuel YW, Cowan RP (2017) Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 372:307–315. https://doi.org/10.1016/j.jns.2016.11.071 CrossRefPubMed

Burstein R, Noseda R, Borsook D (2015) Migraine: multiple processes. complex pathophysiology J Neurosci 35:6619–6629. https://doi.org/10.1523/JNEUROSCI.0373-15.2015 PubMedCrossRef

Blumenfeld AM, Varon SF, Wilcox TK et al (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the international burden of migraine study (IBMS). Cephalalgia 31:301–315. https://doi.org/10.1177/0333102410381145 CrossRefPubMed

Steiner TJ, Stovner LJ, Katsarava Z et al (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15(31). https://doi.org/10.1186/1129-2377-15-31

GBD 2015 DALYs and HALE Collaborators NJ, Arora M, Barber RM et al (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1603–1658. https://doi.org/10.1016/S0140-6736(16)31460-X CrossRef

10.

Steiner TJ, Stovner LJ, Vos T et al (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19:17. https://doi.org/10.1186/s10194-018-0846-2 CrossRefPubMedPubMedCentral

11.

Vos T, Allen C, Arora M et al (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 388:1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6 CrossRef

12.

Cevoli S, D’Amico D, Martelletti P et al (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29:1285–1293. https://doi.org/10.1111/j.1468-2982.2009.01874.x CrossRefPubMed

13.

Radtke A, Neuhauser H (2009) Prevalence and burden of headache and migraine in Germany. Headache 49:79–89. https://doi.org/10.1111/j.1526-4610.2008.01263.x CrossRefPubMed

14.

Ford JH, Jackson J, Milligan G et al (2017) A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns. Headache J Head Face Pain 57:1532–1544. https://doi.org/10.1111/head.13202 CrossRef

15.

Buse DC, Manack AN, Fanning KM et al (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American migraine prevalence and prevention study. Headache 52:1456–1470. https://doi.org/10.1111/j.1526-4610.2012.02223.x CrossRefPubMed

16.

Stokes M, Becker WJ, Lipton RB et al (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the international burden of migraine study (IBMS). Headache 51:1058–1077. https://doi.org/10.1111/j.1526-4610.2011.01945.x CrossRefPubMed

17.

Edmeads J, Mackell JA (2002) The economic impact of migraine: an analysis of direct and indirect costs. Headache 42:501–509CrossRefPubMed

18.

Sharma K, Remanan R, Singh S (2013) Quality of life and psychiatric co-morbidity in Indian migraine patients: a headache clinic sample. Neurol India 61:355–359. https://doi.org/10.4103/0028-3886.117584 CrossRefPubMed

19.

Ayzenberg I, Katsarava Z, Sborowski A et al (2014) Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol 21:758–765. https://doi.org/10.1111/ene.12380 CrossRefPubMed

20.

Wang S-J, Wang P-J, Fuh J-L et al (2013) Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan. Cephalalgia 33:171–181. https://doi.org/10.1177/0333102412468668 CrossRefPubMed

21.

Berra E, Sances G, De Icco R et al (2015) Cost of chronic and episodic migraine. A pilot study from a tertiary headache Centre in northern Italy. J Headache Pain 16:532. https://doi.org/10.1186/s10194-015-0532-6 CrossRefPubMed

22.

Raggi A, Giovannetti AM, Schiavolin S et al (2014) Validating the migraine-specific quality of life questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse. Qual Life Res 23:1273–1277. https://doi.org/10.1007/s11136-013-0556-9 CrossRefPubMed

23.

Stuginski-Barbosa J, Dach F, Bigal M, Speciali JG (2012) Chronic pain and depression in the quality of life of women with migraine - a controlled study. Headache J Head Face Pain 52:400–408. https://doi.org/10.1111/j.1526-4610.2012.02095.x CrossRef

24.

Andrée C, Stovner LJ, Steiner TJ et al (2011) The Eurolight project: the impact of primary headache disorders in Europe. Description of methods. J Headache Pain 12:541–549. https://doi.org/10.1007/s10194-011-0356-y CrossRefPubMedPubMedCentral

25.

Bloudek LM, Stokes M, Buse DC et al (2012) Cost of healthcare for patients with migraine in five European countries: results from the international burden of migraine study (IBMS). J Headache Pain 13:361–378. https://doi.org/10.1007/s10194-012-0460-7 CrossRefPubMedPubMedCentral

26.

Fernández-de-Las-Peñas C, Hernández-Barrera V, Carrasco-Garrido P et al (2010) Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions. J Headache Pain 11:97–104. https://doi.org/10.1007/s10194-009-0176-5 CrossRefPubMed

27.

Allena M, Steiner TJ, Sances G et al (2015) Impact of headache disorders in Italy and the public-health and policy implications: a population-based study within the Eurolight project. J Headache Pain 16:100. https://doi.org/10.1186/s10194-015-0584-7 CrossRefPubMedPubMedCentral

28.

D’Amico D, Bussone G (2003) Disability and migraine: recent outcomes using an Italian version of MIDAS. J Headache Pain 4:s42–s46. https://doi.org/10.1007/s101940300008 CrossRefPubMedCentral

29.

Mesas AE, González AD, Mesas CE et al (2014) The association of chronic neck pain, low back pain, and migraine with absenteeism due to health problems in Spanish workers. Spine (Phila Pa 1976) 39:1243–1253. https://doi.org/10.1097/BRS.0000000000000387 CrossRef

30.

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed

31.

Maruish ME (Ed.) (2011) User’s manual for the SF-36v2 Health Survey (3rd ed.). Lincoln, RI: QualityMetric Incorporated.

32.

Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMed

33.

Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727–1736. https://doi.org/10.1007/s11136-011-9903-x CrossRefPubMedPubMedCentral

34.

Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353–365CrossRefPubMed

35.

Swigris JJ, Brown KK, Behr J et al (2010) The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 104:296–304. https://doi.org/10.1016/j.rmed.2009.09.006 CrossRefPubMed

36.

Walters SJ, Brazier JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14:1523–1532CrossRefPubMed

37.

Meneghini LF, Lee L, Gupta S, Preblick R (2018) The association of hypoglycaemia severity and clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin. Diabetes Obes Metab. https://doi.org/10.1111/dom.13208

38.

Arima K, Gupta S, Gadkari A et al (2018) Burden of atopic dermatitis in Japanese adults: analysis of data from the 2013 National Health and wellness survey. J Dermatol. https://doi.org/10.1111/1346-8138.14218

39.

Ding B, DiBonaventura M, Karlsson N, Ling X (2017) A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and wellness surveys. J Asthma 54:632–643. https://doi.org/10.1080/02770903.2016.1255750 CrossRefPubMed

40.

Balp M-M, Vietri J, Tian H, Isherwood G (2015) The impact of chronic Urticaria from the Patient’s perspective: a survey in five European countries. Patient 8:551–558. https://doi.org/10.1007/s40271-015-0145-9 CrossRefPubMedPubMedCentral

41.

Lipton RB, Hamelsky SW, Kolodner KB et al (2000) Migraine, quality of life, and depression: a population-based case-control study. Neurology 55:629–635CrossRefPubMed

42.

Lipton R, Liberman J, Kolodner K et al (2003) Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 23:441–450. https://doi.org/10.1046/j.1468-2982.2003.00546.x CrossRefPubMed

43.

Arslantas D, Tozun M, Unsal A, Ozbek Z (2013) Headache and its effects on health-related quality of life among adults. Turk Neurosurg 23:498–504. https://doi.org/10.5137/1019-5149.JTN.7304-12.0 PubMedCrossRef

44.

Shaik MM, Hassan NB, Tan HL, Gan SH (2015) Quality of life and migraine disability among female migraine patients in a tertiary Hospital in Malaysia. Biomed Res Int 2015:1–9. https://doi.org/10.1155/2015/523717 CrossRef

45.

Stovner LJ, Andrée C, Committee ES (2008) Impact of headache in Europe: a review for the Eurolight project. J Headache Pain 9:139–146. https://doi.org/10.1007/s10194-008-0038-6 CrossRefPubMedPubMedCentral

46.

Munakata J, Hazard E, Serrano D et al (2009) Economic burden of transformed migraine: results from the American migraine prevalence and prevention (AMPP) study. Headache 49:498–508. https://doi.org/10.1111/j.1526-4610.2009.01369.x CrossRefPubMed

47.

Olesen J, Gustavsson A, Svensson M et al (2012) The economic cost of brain disorders in Europe. Eur J Neurol 19:155–162. https://doi.org/10.1111/j.1468-1331.2011.03590.x CrossRefPubMed

48.

Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703–711. https://doi.org/10.1111/j.1468-1331.2011.03612.x CrossRefPubMed

49.

Goren A, Liu X, Gupta S et al (2013) Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and wellness survey. Am. https://doi.org/10.1371/journal.pone.0071264

50.

Kalsekar I, Wagner J-S, Dibonaventura M, et al (2012) Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. ??? 10:1 . doi: https://doi.org/10.1186/1477-7525-10-81

Title: Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Authors: Pamela Vo
Juanzhi Fang
Aikaterini Bilitou
Annik K. Laflamme
Shaloo Gupta
Publication date: 01-12-2018
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-018-0907-6

At a glance: The STEP trials

Springer Medicine

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Male and female sex hormones in primary headaches

Novel capsaicin-induced parameters of microcirculation in migraine patients revealed by imaging photoplethysmography

Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data

Upper cervical two-point discrimination thresholds in migraine patients and headache-free controls

Altered muscle activity during rest and during mental or physical activity is not a trait symptom of migraine - a neck muscle EMG study

The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research